Clinical trial NCT00970125: Using Video Images to Improve Advance Care Planning in Patients With Cancer
Official title: Using Video Images to Improve Advance Care Planning in Patients With Cancer
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Advanced Cancer
Keywords: advance care planning
cancer
Lead sponsor: Massachusetts General Hospital
Sponsor class: OTHER
First posted: 2009-09-02
Enrollment: 80
Sex: ALL
Minimum age (years): 21
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Detailed description: The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Eligibility criteria: Inclusion Criteria:

1. Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:

   * All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
   * Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
   * Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
   * The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).
2. Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).
3. English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.
4. Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.
5. Able to provide informed consent.
6. Age greater than or equal to 21.

Exclusion Criteria:

1. MMSE \< 25.
2. Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.

Primary outcomes:
measure: end of life preference at time of interview
timeFrame: 5 minutes after survey
Secondary outcomes:
measure: knowledge
timeFrame: 5 minutes after survey
measure: decisional conflict
timeFrame: 5 minutes after survey
Other outcomes:
Locations:
city: New York
country: United States
facility: Memorial Sloan Kettering
state: New York
Study officials:
affiliation: Massachusetts General Hospital
name: Angelo E. Volandes, MD, MPH
role: PRINCIPAL_INVESTIGATOR
References: